Combination Drug, Chemo May Extend Life of Colon Cancer Patients

<p>SUNDAY, Jun 3 (HealthDay News) — Treating advanced-stage colon
cancer patients with a multiple of <span>chemotherapy</span> and a tumor-targeting
drug Avastin appears to lengthen presence among those who have already
undergone a multiple therapy during an surpassing theatre of disease, new
German investigate finds.</p>
<p>Avastin (<span>bevacizumab</span>) works by interfering with a expansion of blood
vessels that tumors need to grow and spread.</p>
<p>In a United States, Avastin already is used in multiple with
chemotherapy as a customary of caring for both initial diagnosis and
second-line treatment, that is for patients who need additional
treatment for surpassing disease.</p>
<p>The stream study’s specific anticipating that Avastin is profitable as a
second go-round for patients with modernized illness could change a way
patients in Europe are treated, given that typically a total therapy
is used possibly as a fi...